MedPath

3D Visualization System in Highly Myopic Cataract Operation

Not Applicable
Recruiting
Conditions
High Myopia
Cataract
Interventions
Procedure: Standard cataract operation
Device: Alcon-NGENUITY®(NG)-system
Registration Number
NCT06264830
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This study aims to investigate the impact of depth of field differences between the use of the 3D imaging system (NGENUITY® 3D Visualization System, Alcon, TX, USA) and conventional optical microscope in cataract surgery for highly myopic patients on intraoperative parameters and outcomes.

Detailed Description

The objective of this study is to compare the surgical outcomes and parameters between cataract surgeries performed using the NGENUITY® 3D Visualization System (Alcon, TX, USA), a 3D imaging system, and the current standard binocular microscope in highly myopic patients. The focus is on evaluating the differences in depth of field and their impact on intraoperative parameters and outcomes.

This prospective randomized controlled trial aims to enroll patients with both high myopia and cataracts requiring surgical intervention. Participants will be randomly assigned to undergo cataract surgery using the current standard binocular microscope (control group) or the NGENUITY® 3D Visualization System (Alcon, TX, USA) (study group). The study will compare intraoperative parameters, surgical outcomes, and the incidence of potential complications, including the frequency of microscope adjustments during surgery, total distance of adjustments during surgery, distance needed to achieve clear focus from the corneal surface to the posterior capsule, surgical duration, cumulative ultrasound energy during surgery, and occurrence of surgical complications.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  1. High myopia (axial length of 26 millimeters or more).
  2. Presence of clinically significant age-related nuclear cataract requiring surgery, assessed using the International Classification System for Cataract (Lens Opacities Classification System III, LOC III), with a graded score indicating nuclear cataract (LOC III NC/NO grade 3-5).
  3. Participants must be 20 years of age or older.
Exclusion Criteria
  1. The target eye has undergone vitrectomy surgery.
  2. The target eye has undergone corneal refractive surgery.
  3. Presence of corneal diseases such as corneal dystrophy, corneal trauma, corneal scarring, corneal ulcers, or clinically significant corneal softening that significantly affects the clarity of cataract surgery.
  4. Complicated cataracts with features such as extreme hardness, complex composition, zonular laxity, lens dislocation, extensive capsular fibrosis, or those falling under the international cataract classification standards LOCIII NO/NC6 or C4-C5 or P4-P5.
  5. Presence of other non-myopia-related eye diseases significantly affecting the complexity of surgery, such as adhesive uveitis causing adhesions, corneal damage due to trauma or lens dislocation, structural changes and adhesions due to intraocular inflammation, or severe uncorrected strabismus affecting eye alignment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional-binocular-microscope-assisted standard cataract operationStandard cataract operationIn this group, patients undergo standard modern cataract operation during which the surgeon use conventional binocular microscope
Alcon-NGENUITY® (NG)-System-assisted standard cataract operationAlcon-NGENUITY®(NG)-systemIn this group, patients undergo standard modern cataract operation during which the surgeon use the Alcon NGENUITY® (NG) System
Alcon-NGENUITY® (NG)-System-assisted standard cataract operationStandard cataract operationIn this group, patients undergo standard modern cataract operation during which the surgeon use the Alcon NGENUITY® (NG) System
Primary Outcome Measures
NameTimeMethod
Distance of subjective focus change in millimeter between corneal surface and surface of posterior capsule, measured by ruler set on microscopeDuring the operation, immediately after lens material is removed, and immediately before the intraocular lens is implanted.

On the microscope one ruler will place on the suspension arm of microscope just beside the sliding joint of main optic lens system. On the side of main optic lens system, there will be a mark. When the surgeon change the focus of the microscope. The mark will change its position relative to the ruler with millimeter in scale. Distance in millimeter of subjective focus between corneal surface and surface of posterior capsule can thus be measured.

Total moving distance in millimeter of microscope-lens-system relative to suspension arm, measured by ruler set on microscopeThroughout operation

On the microscope one ruler will place on the suspension arm of microscope just beside the sliding joint of main optic lens system. On the side of main optic lens system, there will be a mark. When the surgeon change the focus of microscope. The mark will change its position relative to the ruler with millimeter in scale. The total moving distance is the add-ups of all changes during operation in absolute value.

Number of times of Microscopic focus adjustment, measured by counting from the video recordingsThroughout operation

A video recorder will focus on the sliding joint between main suspension arm of microscope and its lens system. Once the surgeon change the focus, the marks on both side of the joint will change their relative positions. The times of changes will be counted from the video recording.

Secondary Outcome Measures
NameTimeMethod
Total operation timeThroughout operation

Total operation time

Number of Participants with post-operative complicationWithin three month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3

Number of Participants with post-operative complication

Best-corrected visual acuity of the operated eye of Participants at each postoperative follow-up within 3 month, measured with Snellen chart under standard condition (6 meters in distance and standard illumination of environment)Within 3 month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3

The best-corrected visual acuity (BCVA) measured with Snellen chart is expected to range from 20/20(1.0) to 20/400(0.05). The refraction of the eye will be carefully corrected using trial lens. The higher the Snellen-chart value, and better the vision. For worse vison. The BCVA will be documented with able to count finger at certain distance ( such as100 centimeter or 30 centimeter). For even worse one, the BCVA will be documented with able to tell hand waving or not at certain distance ( such as100 centimeter or 30 centimeter). For even worse one, the BCVA will be documented with light perception or no light perception.

Cumulative dissipated energy (CDE) of phacoemulsification, that is automatically measured and demonstrated on the screen of phacoemulsification machine (Centurion)Throughout operation

Cumulative dissipated energy (CDE) is defined as mean phaco power times phaco time. CDE will be automatically measured and calculated by the Alcon centurion phacoemulsification machine, and will be demonstrated on the screen of the machine. CDE is itself the unit. The lower the CDE for an operation, the better.

Number of Participants with intraoperative complicationThroughout operation

Number of Participants with intraoperative complication

Intraocular pressure of the operated eye of participants at each postoperative follow-up within 3 month, measured with pneumatic tonometerWithin 3 month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3

The intraocular pressure will be measured with pneumatic tonometer

Trial Locations

Locations (1)

Department of Ophthalmology, National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath